Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

EIPA (hydrochloride)

EIPA (L593754) hydrochloride is an orally active TRPP3 channel inhibitor with an IC50 of 10.5 μM. EIPA hydrochloride also enhances autophagy by inhibiting Na+/H+-exchanger 3 (NHE3) . EIPA hydrochloride inhibits macropinocytosis as well. EIPA hydrochloride can be used in the research of inflammation and cancers, such as gastric cancer, colon carcinoma, pancreatic carcinoma[1][2][3][5].

Product Specifications

CAS Number

[1345839-28-2]

Product Name Alternative

L593754 (hydrochloride) ; MH 12-43 (hydrochloride) ; Ethylisopropylamiloride (hydrochloride)

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Autophagy; COX; Na+/H+ Exchanger (NHE) ; Prostaglandin Receptor; TRP Channel

Type

Reference compound

Related Pathways

Autophagy; GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/eipa-hydrochloride.html

Concentration

10mM

Purity

98.31

Solubility

DMSO : 130 mg/mL (ultrasonic)

Smiles

O=C(C1=NC(Cl)=C(N(CC)C(C)C)N=C1N)NC(N)=N.Cl

Molecular Formula

C11H19Cl2N7O

Molecular Weight

336.22

Precautions

H302, H315, H319, H335

References & Citations

[1]Dai XQ, et al. Inhibition of TRPP3 channel by MK-870 and analogs. Mol Pharmacol. 2007 Dec;72 (6) :1576-85.|[2]Shi H, et al. Na+/H+ Exchanger Regulates Amino Acid-Mediated Autophagy in Intestinal Epithelial Cells. Cell Physiol Biochem. 2017;42 (6) :2418-2429.|[3]Zhu BY, et al. A new HDAC inhibitor cinnamoylphenazine shows antitumor activity in association with intensive macropinocytosis.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

COX-2

Citation 01

Acta Biomater. 2024 Feb:175:250-261.|Cancer Cell. 2025 Jul 15:S1535-6108 (25) 00271-5.|Emerg Microbes Infect. 2022 Dec;11 (1) :1135-1144.|J Cell Biol. 2025 May 5;224 (5) :e202405060.|J Nanobiotechnology. 2022 Jul 20;20 (1) :340.|Mol Pharm. 2021 Oct 4;18 (10) :3750-3762.|ACS Appl Mater Interfaces. 2020 Oct 14;12 (41) :45763-45771.|ACS Nano. 2020 Nov 24;14 (11) :14698-14714.|ACS Nano. 2024 Sep 11.|ACS Nano. 2025 Aug 19;19 (32) :29341-29359.|Adv Funct Mater. 2021 Apr 1.|Adv Healthc Mater. 2025 Jul 9:e2500592.|Adv Healthc Mater. 2025 May 19:e2500546.|Adv Healthc Mater. 2025 May 24:e2500507.|Adv Mater. 2025 Jan 10:e2415030.|Adv Sci (Weinh) . 2024 Nov 6:e2412014.|Adv Sci (Weinh) . 2025 Mar 27:e2415684.|Adv Sci (Weinh) . 2025 Sep 3:e02788.|Anal Chem. 2020 Jan 21;92 (2) :2103-2111.|Autophagy. 2023 Mar;19 (3) :839-857.|Biochim Biophys Acta Gen Subj. 2023 Mar;1867 (3) :130300.|Biol Open. 2023 Nov 15;12 (11) :bio060081.|Biomacromolecules. 2021 Sep 13;22 (9) :3679-3691.|Biomaterials. 2022 Feb:281:121373.|Bioorg Chem. 2022 Apr:121:105651.|bioRxiv. 2024 Jan 10:2024.01.07.574541.|bioRxiv. 2025 May 3:2025.04.29.651251.|bioRxiv. 2025 Nov 20.|Biotechnol J. 2023 Feb;18 (2) :e2200393.|BMC Plant Biol. 2025 Feb 7;25 (1) :159.|Bone Res. 2025 Oct 20;13 (1) :88.|Cancer Drug Resist. 2025 Aug 27:8:45.|Cancer Res. 2025 Jul 15;85 (14) :2659-2678.|Cancer Res. 2025 Oct 9.|Carbohydr Polym. 2025 Nov 15;368 (Pt 1) :124067.|Carcinogenesis. 2024 Jul 15:bgae045.|Cell Death Dis. 2025 Apr 5;16 (1) :253.|Cell Metab. 2022 Dec 6;34 (12) :2018-2035.e8.|Chem Eng J. 2024 Sep 1.|Clin Transl Med. 2025 Jan;15 (1) :e70191.|Comput Struct Biotechnol J. 2021;19:1933-1943.|Drug Deliv. 2021 Dec;28 (1) :800-813.|Eur J Pharm Sci. 2025 Sep 1:212:107188.|Exp Hematol. 2024 Dec:140:104651.|Genes Dev. 2021 Oct 1;35 (19-20) :1327-1332.|Int Immunopharmacol. 2025 May 30:160:114918.|Int J Biol Macromol. 2025 Apr 28;310 (Pt 4) :143599.|Int J Mol Sci. 2025 Mar 29;26 (7) :3172.|iScience. 2023 Apr 7;26 (5) :106598.|J Biol Chem. 2022 Nov;298 (11) :102511.|J Control Release. 2022 Nov:351:703-712.|J Control Release. 2023 Mar:355:675-684.|J Control Release. 2024 Jun:370:140-151.|J Control Release. 2025 Aug 29:387:114176.|J Control Release. 2025 Jun 6:113939.|J Exp Med. 2023 Mar 6;220 (3) :e20221316.|J Hazard Mater. 2021 Sep 5;417:126092.|J Nanobiotechnology. 2022 Jun 10;20 (1) :268.|J Neuroinflammation. 2024 May 10;21 (1) :125.|J Pathol. 2023 May;260 (1) :17-31.|J Virol. 2021 Nov 23;95 (24) :e0134521.|J Virol. 2025 Aug 25:e0022125.|Mater Today Bio. 2025 Nov 13:35:102547.|Matter. 2023 Aug 31.|Microb Pathog. 2025 May 26:206:107751.|Microvasc Res. 2021 Nov:138:104219.|Nanotoxicology. 2022 Nov-Dec;16 (9-10) :895-912.|Nat Commun. 2024 Jan 2;15 (1) :162.|Nat Commun. 2025 Feb 4;16 (1) :1327.|Nat Commun. 2025 Sep 26;16 (1) :8522.|Nat Nanotechnol. 2025 Feb;20 (2) :296-302.|Pharmaceutics. 2020 Feb 17;12 (2) :167.|Pharmaceutics. 2024 Nov 21.|PLoS Pathog. 2024 Nov 21;20 (11) :e1012681.|Polym Sci Technol. 2025 Sep 15.|Sci Adv. 2020 Aug 12;6 (33) :eaaz1774.|Sci China Life Sci. 2022 Feb;65 (2) :341-361.|Sci China Mater. 63, 620-628 (2020) .|Signal Transduct Target Ther. 2025 Oct 21;10 (1) :349.|SSRN. 2025 Sep 30.|Theranostics. 2022 Jan 1;12 (3) :1061-1073.|Vet Res. 2023 Mar 14;54 (1) :24.|Viruses. 2021 May 31;13 (6) :1035.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Lentiviral human TMEM119 sgRNA gene knockout kit - Lentiviral human TMEM119 sgRNA gene knockout kit (100)
GTR15373870 1 Vial

Lentiviral human TMEM119 sgRNA gene knockout kit - Lentiviral human TMEM119 sgRNA gene knockout kit (100)

Ask
View Details
Rabbit Anti-Human IRAKM monoclonal antibody, clone TO75-18
CABT-L729 100 ul

Rabbit Anti-Human IRAKM monoclonal antibody, clone TO75-18

Ask
View Details
Biotinyl-Glucagon (1-29), human, bovine, porcine
MF-0155954-01 5 mg

Biotinyl-Glucagon (1-29), human, bovine, porcine

Ask
View Details
Biotinyl-Glucagon (1-29), human, bovine, porcine
MF-0155954-02 50 mg

Biotinyl-Glucagon (1-29), human, bovine, porcine

Ask
View Details
Human C15orf60 knockout cell line
ABC-KH1761 1 Vial

Human C15orf60 knockout cell line

Ask
View Details